Results 151 to 158 of about 5,939 (158)

Upadacitinib for the treatment of rheumatoid arthritis

Expert Review of Clinical Immunology, 2019
Christopher Edwards
exaly  

Efficacy and tolerability of oral upadacitinib monotherapy in patients with recalcitrant vitiligo

Journal of the American Academy of Dermatology, 2023
exaly  

Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics

Journal of Clinical Pharmacology, 2019
Ahmed A Othman, Tian Feng
exaly  

Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended‐Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials

Clinical Pharmacology in Drug Development, 2019
Ahmed A Othman
exaly  

Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies

International Immunopharmacology
Cong Dai, Yu-Hong Huang
exaly  

Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study

International Immunopharmacology
Yumei Liu, Aili Gao
exaly  

Upadacitinib in Autoimmune Enteropathy—A Case Report

Inflammatory Bowel Diseases
Peter De Cruz, Simone Chin, Darren Wong   +2 more
exaly  

Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients

Frontiers in Medicine
exaly